ClinicalTrials.gov
public full text
Public Domain
Clavulanic Acid for the Treatment of Cocaine Use Disorder
A dose escalation study to assess the efficacy and safety of Clavulanic Acid (CLAV) vs. placebo (PBO) for the treatment of cocaine use disorder (CUD)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction#827429
- Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine Reinforcement#1030771
- Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9#853828
- Digital Therapeutic Content for Substance Use Disorder Treatment: Development and Evaluation Study.#172046
- Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation#834831
Record · ID 969682
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive